Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma Academic Article uri icon

Overview

MeSH Major

  • Fibroma
  • Sarcoma

abstract

  • Percent myxoid component and tumor size are the two most important predictors of DSS and DRFS in high-grade myxofibrosarcoma and UPS. A 5% myxoid component cutpoint is an improved criterion for classifying myxofibrosarcoma. Myxoid component-based classification improves stratification of patient outcome and will aid in selection of patients for systemic therapy and clinical trials.

publication date

  • March 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4964786

Digital Object Identifier (DOI)

  • 10.1245/s10434-015-5063-5

PubMed ID

  • 26759307

Additional Document Info

start page

  • 818

end page

  • 25

volume

  • 23

number

  • 3